Cryo-Cell International
CCEL
17 hedge funds and large institutions have $3.38M invested in Cryo-Cell International in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.06% less ownership
Funds ownership: 12.27% → 12.2% (-0.06%)
15% less funds holding
Funds holding: 20 → 17 (-3)
26% less capital invested
Capital invested by funds: $4.59M → $3.38M (-$1.21M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$13K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.95K |
| 3 |
BlackRock
New York
|
+$2.14K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$436 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$340 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$47.3K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.03K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$83 |
| 4 |
JP Morgan Chase
New York
|
-$51 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$9 |
CCEL Hedge Fund Activity: Q4 2025 in Review
17 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q4 2025, worth a combined $3.38M — down 26% from $4.59M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CCEL and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, adding an estimated $13K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $47.3K sold.
- 17 institutional investors held Cryo-Cell International (CCEL) as of Q4 2025, down from 20 in Q3 2025.
- Funds reported $3.38M of Cryo-Cell International stock for Q4 2025, down 26% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q4 2025 and 4 closed out, a net change of -3 holders.
- The largest Cryo-Cell International buyer in Q4 2025 was Citadel Advisors, an estimated $13K added.
- The largest Cryo-Cell International seller in Q4 2025 was Renaissance Technologies, an estimated $47.3K sold.
Based on aggregated 13F filings for Q4 2025.